Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

$30.00

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety and Safety
By Matthew T. Morris, Sandip P. Tarpada

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 47 No. 2 Articles - 2017 Tags: antipsychotic-medication, efficacy-and-safety, evidence-based-medicine, matthew-t-morris, paliperidone-palmitate, psychopharmacology, sandip-p-tarpada, schizophrenia

Description

Description

EVIDENCE-BASED MEDICINE
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
and Safety
By Matthew T. Morris, Sandip P. Tarpada

42-52_PB-47-2-2017_Morris

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Description

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Schizophrenia and Valproate

Risperidone: Review of Its Therapeutic Utility in Depression

Neuropsychiatric Update: Neuroimaging Schizophrenia

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety

Description

Related products

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Schizophrenia and Valproate

Risperidone: Review of Its Therapeutic Utility in Depression

Neuropsychiatric Update: Neuroimaging Schizophrenia